Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Resveratrol is a polyphenolic compound found in grapes, berries, and peanuts, and has been studied for its potential neuroprotective properties, including applications in Parkinson’s Disease (PD). Preclinical studies in cell cultures and animal models suggest that resveratrol may exert beneficial effects in PD by reducing oxidative stress, inhibiting neuroinflammation, and modulating mitochondrial dysfunction—processes implicated in the degeneration of dopaminergic neurons characteristic of PD. Some studies have shown that resveratrol can activate sirtuin 1 (SIRT1) and enhance autophagy, potentially protecting neurons against toxin-induced death in PD models.

However, despite these promising laboratory findings, high-quality human clinical trials investigating resveratrol’s effect on Parkinson’s Disease are sparse or lacking altogether. Most evidence is limited to preclinical studies, and there is insufficient data on effective dosing, safety, and clinical outcomes in PD patients. Thus, while the use of resveratrol in PD is rooted in scientific rationale and supported by preliminary research, it cannot be considered an evidence-based therapy at this time. Its use should be regarded as experimental, and patients should not substitute resveratrol for established PD treatments. Further clinical studies are needed to determine whether these laboratory findings translate into meaningful benefits for people living with Parkinson’s Disease.

More about resveratrol
More about Parkinson's Disease

Other ingredients used for Parkinson's Disease

Other health conditions supported by resveratrol

Products containing resveratrol

Nature's Sunshine Cardio Assurance
Nature's Sunshine Cholester-Reg II
Nature's Sunshine Nattozimes Plus
Nature's Sunshine Solstic Cardio
Nature's Sunshine Super ORAC